Journal of Cerebral Blood Flow and Metabolism Changes in N-acetyl-aspartate Content during Focal and Global Brain Ischemia of the Rat

N-Acetyl-aspartate (NAA) is almost exclusively localized in neurons in the mature brain and might be used as a neuronal marker. It has been reported that the NAA content in human brain is decreased in neurodegenerative diseases and in stroke. Since the NAA content can be determined by nuclear magnetic resonance techniques, it has potential as a diagnostic and prognostic marker. The objective of this study was to examine the change of NAA content and related substances following cerebral ischemia and compare the results to the damage of the tissue. We used rats to study the changes of NAA, N-acetyl-aspartyl-glutamate (NAAG), glutamate, and aspartate contents over a time course of 24 h in brain regions affected by either permanent middle cerebral artery occlusion (focal ischemia) or decapitation (global ischemia). The decreases of NAA and NAAG contents following global brain ischemia were linear over time but significant only after 4 and 2 h, respectively. After 24 h, the levels of NAA and NAAG were 24 and 44% of control values, respectively. The concentration of glutamate did not change, whereas the aspartate content increased at a rate comparable with the rate of decrease of NAA content. This is consistent with NAA being preferentially degraded by the enzyme amidohydrolase II in global ischemia. In focal ischemia, there was a rapid decline of NAA within the first 8 h of ischemia followed by a slower rate of reduction. The reductions of NAA and NAAG contents in focal ischemia were significant after 4 and 24 h, respectively. After 24 h, the NAA and NAAG contents were 33 and 64% of control values, respectively. Also, the glutamate and aspartate contents exhibited significant decreases in focal ischemic tissue. Our studies show that NAA decreases during brain ischemia, the initial rate being faster in focal ischemia than in global ischemia. In rat transient focal ischemia, others have shown that a middle cerebral artery occlusion of 2- to 3-h duration is sufficient to produce an infarct that is similar in size to that following permanent occlusion for 24 h. The fact that we observed only a 10% decrease of NAA content 2 h after occlusion demonstrates that the NAA content of the tissue does not reflect neuronal viability. Thus, the incompetence with which ischemic/infarcted tissue removes NAA will lead to overestimation of the number of viable neurons in acute situations. Only when steady state prevails may [NAA] be used as a marker of viable nerve cells.

[1]  Y. Lampl,et al.  Cerebrospinal fluid lactate dehydrogenase levels in early stroke and transient ischemic attacks. , 1990, Stroke.

[2]  …AND TRANSIENT ISCHEMIC ATTACKS , 1980 .

[3]  William H. Oldendorf,et al.  N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.

[4]  A. Hamberger,et al.  Ischemia-Induced Shift of Inhibitory and Excitatory Amino Acids from Intra- to Extracellular Compartments , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  L. Berlinguet,et al.  Metabolism of N-acetyl-L-aspartic acid in mice. , 1966, Canadian journal of biochemistry.

[6]  T. Perry,et al.  Postmortem Changes of Amino Compounds in Human and Rat Brain , 1981, Journal of neurochemistry.

[7]  G. Rosner,et al.  Elevation of Neuroactive Substances in the Cortex of Cats during Prolonged Focal Ischemia , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  J. Frahm,et al.  Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy , 1989, Magnetic resonance in medicine.

[9]  A. Betz,et al.  Attenuated Development of Ischemic Brain Edema in Vasopressin-Deficient Rats , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  A. Brancati,et al.  Distribution of N-acetylaspartate, N-acetylaspartylglutamate, free glutamate and aspartate following complete mesencephalic transection in rat neuraxis , 1990, Neuroscience Letters.

[11]  D. Graham,et al.  Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  J. Cooper,et al.  N‐ACETYL‐l‐ASPARTIC ACID CONTENT OF HUMAN NEURAL TUMOURS AND BOVINE PERIPHERAL NERVOUS TISSUES , 1972, Journal of neurochemistry.

[13]  A. Lajtha,et al.  Decreased brain N-acetylaspartate in Huntington's disease , 1992, Brain Research.

[14]  T. Olsen,et al.  Early Time Course of N‐Acetylaspartate, Creatine and Phosphocreatine, and Compounds Containing Choline in the Brain After Acute Stroke: A Proton Magnetic Resonance Spectroscopy Study , 1992, Stroke.

[15]  A. Betz,et al.  Ischemic Brain Edema in Vasopressin- Deficient Rats , 1992 .

[16]  R. Bryan,et al.  Irreversible regional cerebral ischemia: serial MR imaging and proton MR spectroscopy in a nonhuman primate model. , 1993, AJNR. American journal of neuroradiology.

[17]  H. Tallan,et al.  N-Acetyl-L-aspartic acid in brain. , 1956, The Journal of biological chemistry.

[18]  T. Nakada,et al.  In vivo 1H and 31P NMR spectroscopy of the developing rat brain , 1992, Magnetic resonance in medicine.

[19]  H. Tallan Studies on the distribution of N-acetyl-L-aspartic acid in brain. , 1957, The Journal of biological chemistry.

[20]  K. Jacobson Studies on the Role of N-Acetylaspartic Acid in Mammalian Brain , 1959, The Journal of general physiology.

[21]  A. Plaitakis,et al.  Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartylglutamate in amyotrophic lateral sclerosis , 1993, Brain Research Bulletin.

[22]  W. Pulsinelli,et al.  Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. , 1991, Stroke.

[23]  W. Heiss,et al.  Ischemia‐Induced Accumulation of Extracellular Amino Acids in Cerebral Cortex, White Matter, and Cerebrospinal Fluid , 1993, Journal of neurochemistry.

[24]  B. Siesjö,et al.  Penumbral Tissues Salvaged by Reperfusion Following Middle Cerebral Artery Occlusion in Rats , 1992, Stroke.

[25]  M. Weiner,et al.  Elevated Lactate and Alkalosis in Chronic Human Brain Infarction Observed by 1H and 31P MR Spectroscopic Imaging , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  R. Grossman,et al.  Volume and surface area estimates of astrocytes in the sensorimotor cortex of the cat , 1980, Neuroscience.

[27]  M Noble,et al.  Specific Expression of N‐Acetylaspartate in Neurons, Oligodendrocyte‐Type‐2 Astrocyte Progenitors, and Immature Oligodendrocytes In Vitro , 1992, Journal of neurochemistry.

[28]  J. Coyle,et al.  Abnormal acidic amino acids and N-acetylaspartylglutamate in hereditary canine motoneuron disease , 1993, Brain Research.

[29]  N. Herschkowitz,et al.  N-acetyl-L-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. , 1991, Developmental neuroscience.

[30]  G. A. Walter,et al.  Hypoxia/hypotension evoked release of glutamate and aspartate from the rat cerebral cortex , 1989, Neuroscience Letters.

[31]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  J. Coyle,et al.  Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. , 1987, The Journal of biological chemistry.

[33]  E. Jellum,et al.  N-acetylaspartic aciduria in a child with a progressive cerebral atrophy. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[34]  S. Marklund,et al.  Release of Superoxide Dismutase Into Cerebrospinal Fluid as a Marker of Brain Lesion in Acute Cerebral Infarction , 1992, Stroke.

[35]  A. Blamire,et al.  Spectroscopic imaging of stroke in humans , 1992, Neurology.

[36]  R. Keep,et al.  Blood—Brain Barrier Permeability and Brain Concentration of Sodium, Potassium, and Chloride during Focal Ischemia , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  R G Shulman,et al.  Proton Magnetic Resonance Spectroscopy of Cerebral Lactate and Other Metabolites in Stroke Patients , 1992, Stroke.

[38]  J. Coyle,et al.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[39]  F. Goldstein AMIDOHYDROLASES OF BRAIN; 1 ENZYMATIC HYDROLYSIS OF N‐ACETYL‐l‐ASPARTATE AND OTHER N‐ACYL‐l‐AMINO ACIDS , 1976, Journal of neurochemistry.

[40]  J. Coyle,et al.  N‐Acetyl‐Aspartyl‐Glutamate: Regional Levels in Rat Brain and the Effects of Brain Lesions as Determined by a New HPLC Method , 1984, Journal of neurochemistry.

[41]  F. Goldstein Biosynthesis of N-acetyl-L-aspartic acid. , 1959, Biochimica et biophysica acta.

[42]  P. Matthews,et al.  A proton magnetic resonance spectroscopy study of focal epilepsy in humans , 1990, Neurology.

[43]  G. Fein,et al.  Reduced brain N‐acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus‐seropositive individuals , 1993, Neurology.

[44]  A. Blamire,et al.  Early Temporal Variation of Cerebral Metabolites After Human Stroke: A Proton Magnetic Resonance Spectroscopy Study , 1993, Stroke.